Consensus DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2026-10-30 pm EDT			5-day change	1st Jan Change
82.29 ^USD	+2.95%		+5.58%	+23.99%

Oct. 30	DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says	MT
Oct. 30	UBS Adjusts DexCom Price Target to $107 From $102, Maintains Buy Rating	MT

Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

b0ab677b56a569997f1.MnE3aagQGVQXZWsarOGru11TOYhbN49B1hRV6k8abD4.eAJfK8djLQx6MiN224vB7Q9jcNpicP93o0ZihRt2LU5eGV0oxn1AO0gdJg~85a44ba852e7a395831194493b876476

Analysts' recommendations: DexCom, Inc.

Oct. 30	DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says	MT
Oct. 30	UBS Adjusts DexCom Price Target to $107 From $102, Maintains Buy Rating	MT
Oct. 30	Raymond James Adjusts Price Target on DexCom to $97 From $94	MT
Oct. 30	Barclays Adjusts Price Target on DexCom to $120 From $115	MT
Oct. 26	Leerink Partners Adjusts Price Target on DexCom to $87 From $94	MT
Oct. 13	Mizuho Adjusts Price Target on DexCom to $100 From $95	MT
Oct. 12	BTIG Adjusts Price Target on DexCom to $96 From $90	MT
Oct. 07	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
Oct. 01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
Sep. 17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
Aug. 13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
Aug. 04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
Aug. 03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
Aug. 03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
Jul. 31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
Jul. 31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
Jul. 31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
Jul. 31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
Jul. 31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
Jul. 31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
Jul. 31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
Jul. 31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
Jul. 31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
Jul. 31	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
Jul. 31	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DEXCOM, INC.					+17.83%
	ABBOTT LABORATORIES					+11.6%
	STRYKER CORPORATION					+20.07%
	MEDTRONIC PLC					+8.36%
	ESSILORLUXOTTICA					+17.15%
	CENCORA, INC.					+12.34%
	HOYA CORPORATION					+16.9%
	BECTON, DICKINSON AND COMPANY					-1.17%
	IDEXX LABORATORIES, INC.					+25.98%
	ALCON INC.					+25.55%
	Average					+15.46%
	Weighted average by Cap.					+14.19%